Delivery Order SPE2DB20D1100-SPE2DB25FC8U4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of etonogestrel-ethinyl estradiol (EE) vaginal rings, with a ceiling value of $1,456.73. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The work is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 31, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,331.42 and is scheduled for completion by August 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,703.65 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol vaginal rings on June 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,432.38 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order, with no set-aside designation, represents a routine procurement of a hormonal contraceptive product to support military healthcare needs. The order is being fulfilled from AmerisourceBergen's place of performance in...
- The Defense Logistics Agency awarded a delivery order valued at $3,228.12 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol vaginal rings, with an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings valued at $1,793.40 under a firm fixed price contract type. The award, made on August 12, 2025, represents a single delivery order with an ultimate completion date of August 13, 2025, and involves no set-aside designation, indicating competitive award. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,345.05 delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 11, 2025, with completion by August 12, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $2,386.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings, with completion scheduled for September 16, 2025. This non-set-aside contract represents a routine pharmaceutical procurement through the federal medical supply chain, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,152.08 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings. This firm fixed-price delivery order, valued at $1,345.05, is scheduled for completion by September 2, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC8U4Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings, with a contract ceiling value of $1,614.06. This is a non-set-aside, competitively awarded delivery order that will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 13, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a comprehensive range of pharmaceutical products and medical supplies. The company's extensive portfolio of federal contract awards demonstrates consistent capability to meet competitive procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key strategic partner in supporting military medical supply chains globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/12/25 |